The Boeing Company (BA)
AI stock analysis · Aerospace & Defense · Last analyzed Aug 19, 2026
Boeing's bull thesis rests on a multi-year production recovery in its commercial aircraft backlog — one of the largest in history — with 737 MAX and 787 Dreamliner deliveries expected to accelerate meaningfully through 2025–2026, driving a potential normalization of earnings from deeply depressed levels. Revenue growth of 8.0% YoY confirms the top-line recovery is underway, and an overwhelmingly bullish analyst consensus (23 Buys, 0 Sells) reflects confidence in the long-term earnings inflection. The key risk is that execution remains fragile: ongoing production disruptions, regulatory scrutiny, and an 81.4x trailing P/E leave little margin for further operational setbacks.
- 737 MAX production rate ramp toward 38/month target in 2025 — each rate increase directly expands delivery revenue and compresses per-unit costs, providing a quantifiable earnings catalyst.
- Upcoming quarterly earnings report offering first visibility into whether free cash flow turns sustainably positive — a critical inflection point the market is pricing in at a significant premium.
- Potential resolution of ongoing FAA production oversight and quality audits — a regulatory green light could unlock delivery acceleration and restore investor confidence in the timeline to normalized margins.
Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.
Start free for 3 days →Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →